A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis
Tony Muchamuel(Enzo Life Sciences (United States)), Marcus Groettrup(University of Konstanz)
Cited by 594
Related Papers
CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2
|Blood|2003|248
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.
|PubMed|2000|144
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
|Cancer Immunology Immunotherapy|2006|118
FAT10 and NUB1L bind to the VWA domain of Rpn10 and Rpn1 to enable proteasome-mediated proteolysis
|Nature Communications|2012|82
The ubiquitin-like modifier FAT10 decorates autophagy targeted S<i>almonella</i> and contributes to resistance of mice
|Journal of Cell Science|2014|61